Containment, Contract Manufacturing, DNA and Life Science

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Containment

Contract Manufacturing

DNA

Life Science

INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet’s EClinicalMedicine

The Pharma Data

DECEMBER 23, 2020

” Dr. Stanley Plotkin , Professor Emeritus at The Wistar Institute, said, “INOVIO’s DNA vaccine appeared to be quite safe with few significant reactions but yet induced both antibody and T cell responses to SARS-CoV-2.” About INOVIO’s DNA Medicines Platform. mg and 2.0

DNA

DNA Vaccination Vaccine Immune Response

Pfizer to Slash COVID-19 Vaccine Manufacturing Time by Almost 50 Percent

XTalks

FEBRUARY 11, 2021

The increased production aims will be achieved through both improved manufacturing efficiency and increasing build capacity. The drugmaker is targeting various steps in the manufacturing process, beginning right at the DNA stage, which is required as the template from which the mRNA for the SARS-CoV-2 spike protein in the vaccine is made.

Manufacturing

Manufacturing Vaccination Vaccine DNA

Clinical Research Informer

INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, INO-4800 in The Lancet’s EClinicalMedicine

Pfizer to Slash COVID-19 Vaccine Manufacturing Time by Almost 50 Percent

Stay Connected